Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Antivirals-Covid-19-HIV/JCV/HBV/HCV/Zika/Ebola by Palisades Therapeutics for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
Antivirals-Covid-19-HIV/JCV/HBV/HCV/Zika/Ebola is under clinical development by Palisades Therapeutics and currently in Phase I for Coronavirus Disease 2019 (COVID-19). According to...